SCHEMBL9765989

SCHEMBL9765989

CCCC(=O)c1ccccc1N1CCNCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 3/20 0.49
HTR1A P08908 2/20 0.48
HTR2A P28223 2/20 0.48
DRD2 P14416 2/20 0.48
DRD3 P35462 2/20 0.48
DRD4 P21917 1/20 0.48
HTR2C P28335 1/20 0.48
HTR6 P50406 6/20 0.46
HTR3E A5X5Y0 2/20 0.46
HTR3B O95264 2/20 0.46
HTR3A P46098 2/20 0.46
HTR3D Q70Z44 2/20 0.46
HTR3C Q8WXA8 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
HTR7 P34969 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
NCF1 P14598 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27818370 0.88 ADRB1 (0.51) ADRB1HTR1AHTR2ADRD2DRD3
SCHEMBL11665416 0.85 NPC1 (0.59) TSHRHSD17B10LMNAALDH1A1HPGD
SCHEMBL18889531 0.84 HDAC3 (0.49) HTR1AHTR2ADRD2DRD3DRD4
SCHEMBL30637700 0.82 NPC1 (0.56) CYP1A2HSD17B10LMNACYP2C19KDM4E
SCHEMBL501351 0.82 NPC1 (0.56) CYP1A2HSD17B10LMNACYP2C19KDM4E
SCHEMBL6490484 0.81 ADRB1 (0.47) ADRB1HTR1AHTR2ADRD2DRD3
SCHEMBL4313452 0.81 HPGD (0.45) HTR1ADRD2DRD4TSHRHSD17B10
SCHEMBL31349267 0.80 ADRB1 (0.56) ADRB1HTR1AHTR2ADRD2DRD3
SCHEMBL4458672 0.80 ADRB1 (0.56) ADRB1HTR1AHTR2ADRD2DRD3
SCHEMBL5707829 0.79 ADRB1 (0.56) ADRB1HTR1AHTR2ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP disclosed
US-3933824-A Piperazinobutyrophenone derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-01-20 US disclosed